European Commission approves vaccine Flucelvax for Tetra 9 and older
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently,(http:// acompany owned by the Australian Bio
Pharmaceutical(http://, announcedSeqirus, the European Commission, that the European Commission had approved the fluixelvax Tetra for use in people aged 9 and overapproval, making the vaccine The first cell-based vaccine (QIVc) in Europeapproval is based on flucelvax Tetra's "immunogenicity and safety" comparison with another cell-based triaval vaccinedata comes from a flu season in 2017-2018, but the H3N2 virus is the worst in recent years due to the H3N2 virus epidemicStudies have shown that the QIVe vaccine succumbs to changes in the virus that will eventually lead to the QIVe vaccine providing less protection than the QIVc vaccinethe company noted that in December 2018 CIC recognized the benefits of QIVc in its 2019-2020 flu season guide, which states that the vaccine applies to groups over 65 and those at riskin the United States, QIVc was licensed for the first time in 2016 to protect against four influenza viruses, two influenza a viruses (H3N2, H1N1) and two B-type influenza virusesThe vaccine is produced using innovative cell-based technology, avoiding egg adaptation changes associated with traditional egg-based influenza vaccinesAs a result, QIVc can provide a closer match to the pandemic virus and may provide better protection in certain seasons
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
